Predictors of outcomes with covalent BTK inhibitor treatment in relapsed/refractory TP53-mutant mantle cell lymphoma Research Letter

  

Authors:	Uppal, M.; Joseph, A.; Drill, E.; Hamlin, P.; Falchi, L.; Noy, A.; Owens, C.; Epstein-Peterson, Z. D.; Salles, G.; Zelenetz, A. D.; Kumar, A.
Title:	Predictors of outcomes with covalent BTK inhibitor treatment in relapsed/refractory TP53-mutant mantle cell lymphoma
Keywords:	molecular analysis; p53; mutations; lymphomas
Journal Title:	British Journal of Haematology
ISSN:	0007-1048
Publisher:	John Wiley & Sons
Publication status:	Online ahead of print
Date Published:	2025-06-23
Online Publication Date:	2025-06-23
Language:	English
DOI:	10.1111/bjh.20202
PROVIDER:	scopus
PUBMED:	40551465
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-105008760006&doi=10.1111%2fbjh.20202&partnerID=40&md5=08d2fabf2db1c208537037f182e6d4fe
Notes:	Letter -- MSK corresponding author is Anita Kumar -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/226371